Trial Profile
Clinical and Economic Outcomes of Ziconotide Neuromodulation in Italian Cancer Patients
Status:
Completed
Phase of Trial:
Phase II
Latest Information Update: 20 Jan 2011
Price :
$35
*
At a glance
- Drugs Ziconotide (Primary) ; Morphine
- Indications Cancer pain
- Focus Therapeutic Use
- 20 Jan 2011 New trial record